Brian C. Broderick’s Pfizer PFE Stock Holding History

Brian C. Broderick’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$823K	Buy	29,300 +500	+2%	+$13.3K	0.15%	64
2025 Q4	$717K	Hold	28,800	–	–	0.14%	59
2025 Q3	$734K	Sell	28,800 -2,400	-8%	-$59.2K	0.14%	62
2025 Q2	$756K	Hold	31,200	–	–	0.15%	60
2025 Q1	$791K	Hold	31,200	–	–	0.16%	57
2024 Q4	$828K	Hold	31,200	–	–	0.16%	56
2024 Q3	$903K	Sell	31,200 -1,600	-5%	-$46.7K	0.18%	59
2024 Q2	$918K	Sell	32,800 -1,750	-5%	-$48.2K	0.19%	60
2024 Q1	$959K	Buy	34,550 +27,396	+383%	+$760K	0.2%	59
2023 Q4	$206K	Hold	7,154	–	–	0.05%	74
2023 Q3	$237K	Hold	7,154	–	–	0.07%	75
2023 Q2	$262K	Hold	7,154	–	–	0.07%	74
2023 Q1	$292K	Hold	7,154	–	–	0.08%	67
2022 Q4	$367K	Hold	7,154	–	–	0.11%	64
2022 Q3	$313K	Hold	7,154	–	–	0.1%	65
2022 Q2	$376K	Hold	7,154	–	–	0.11%	61
2022 Q1	$370K	Hold	7,154	–	–	0.09%	64
2021 Q4	$422K	Hold	7,154	–	–	0.1%	62
2021 Q3	$307K	Hold	7,154	–	–	0.08%	65
2021 Q2	$280K	Hold	7,154	–	–	0.07%	69
2021 Q1	$259K	Hold	7,154	–	–	0.07%	67
2020 Q4	$264K	Sell	7,154 -386	-5%	-$14.2K	0.08%	69
2020 Q3	$263K	Buy	+7,540	New	+$264K	0.08%	71
2020 Q1	–	Sell	-5,902	Closed	-$219K	–	85
2019 Q4	$219K	Hold	5,902	–	–	0.07%	81
2019 Q3	$201K	Sell	5,902 -211	-3%	-$7.67K	0.07%	83
2019 Q2	$252K	Sell	6,113 -369	-6%	-$14.7K	0.09%	75
2019 Q1	$261K	Sell	6,482 -411	-6%	-$16.5K	0.09%	73
2018 Q4	$285K	Sell	6,893 -843	-11%	-$35K	0.12%	70
2018 Q3	$323K	Sell	7,736 -1,054	-12%	-$40.6K	0.11%	72
2018 Q2	$302K	Sell	8,790 -738	-8%	-$25.2K	0.11%	73
2018 Q1	$321K	Sell	9,528 -738	-7%	-$25.4K	0.12%	73
2017 Q4	$353K	Sell	10,266 -10,164	-50%	-$347K	0.13%	71
2017 Q3	$691K	Hold	20,430	–	–	0.25%	66
2017 Q2	$651K	Sell	20,430 -370	-2%	-$11.7K	0.24%	69
2017 Q1	$676K	Sell	20,800 -1,897	-8%	-$59.8K	0.28%	63
2016 Q4	$699K	Sell	22,697 -527	-2%	-$16.1K	0.3%	59
2016 Q3	$747K	Sell	23,224 -2,459	-10%	-$82.2K	0.32%	59
2016 Q2	$858K	Hold	25,683	–	–	0.36%	57
2016 Q1	$722K	Buy	25,683 +1,951	+8%	+$55.7K	0.31%	61
2015 Q4	$727K	Buy	23,732 +6,485	+38%	+$204K	0.33%	65
2015 Q3	$514K	Sell	17,247 -1,581	-8%	-$50.7K	0.24%	68
2015 Q2	$600K	Sell	18,828 -2,006	-10%	-$65.4K	0.26%	68
2015 Q1	$689K	Buy	20,834 +3,411	+20%	+$108K	0.29%	67
2014 Q4	$515K	Sell	17,423 -1,009	-5%	-$28.9K	0.22%	71
2014 Q3	$518K	Buy	18,432 +1,009	+6%	+$28.3K	0.23%	73
2014 Q2	$490K	Hold	17,423	–	–	0.22%	72
2014 Q1	$531K	Hold	17,423	–	–	0.26%	68
2013 Q4	$506K	Hold	17,423	–	–	0.25%	70
2013 Q3	$475K	Sell	17,423 -421	-2%	-$11.5K	0.26%	67
2013 Q2	$474K	Buy	+17,844	New	+$493K	0.28%	66

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Brian C. Broderick's PFE Position: Q1 2026 in Review

Brian C. Broderick increased its Pfizer (PFE) stake by 1.7% in Q1 2026, buying an estimated $13.3K and bringing the position to 29,300 shares worth $823K. The position accounts for 0.15% of the portfolio, ranked #64.

Brian C. Broderick first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $959K in Q1 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Brian C. Broderick held 29,300 shares of Pfizer worth $823K as of Q1 2026.
Brian C. Broderick bought 500 Pfizer shares in Q1 2026, an estimated $13.3K.
Pfizer made up 0.15% of Brian C. Broderick's portfolio in Q1 2026, its #64 holding.
Brian C. Broderick first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
Brian C. Broderick's Pfizer position peaked at $959K in Q1 2024.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.